Evaluation of non-vendor magnetic resonance imaging sequences for use in bladder cancer magnetic resonance image guided radiotherapy.
Date
2023-07-01Author
Chick, J
Alexander, S
Herbert, T
Huddart, R
Ingle, M
Mitchell, A
Nill, S
Oelfke, U
Dunlop, A
Hafeez, S
Type
Journal Article
Metadata
Show full item recordAbstract
Hybrid systems that combine Magnetic Resonance Imaging (MRI) and linear accelerators are available clinically to guide and adapt radiotherapy. Vendor-approved MRI sequences are provided, however alternative sequences may offer advantages. The aim of this study was to develop a systematic approach for non-vendor sequence evaluation, to determine safety, accuracy and overall clinical application of two potential sequences for bladder cancer MRI guided radiotherapy. Non-vendor sequences underwent and passed clinical image qualitative review, phantom quality assurance, and radiotherapy planning assessments. Volunteer workflow tests showed the potential for one sequence to reduce workflow time by 27% compared to the standard vendor sequence.
Collections
Subject
Adaptive radiotherapy
Bladder cancer
MRI guided radiotherapy
MRI sequence evaluation
Non-vendor sequences
Quality assurance
Research team
Royal Marsden Hospital - Sutton
Clinic Acad RT Huddart
Gynaecological Cancer
Radiother Phys Modelling
Language
eng
Date accepted
2023-08-11
License start date
2023-07-01
Citation
Physics and Imaging in Radiation Oncology, 2023, 27 pp. 100481 -
Publisher
ELSEVIER